shadow_tr


Study Finder

Tulane Cancer Center Research > Office of Clinical Research > Clinical Trials Study Finder > Hematopoietic Failure & Genetic Diseases Transplant Studies

Hematopoietic Failure & Genetic Diseases Transplant
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

BMT 2001-01
G-CSF Primed Donor Leukocyte Infusion (G-DLI) for Treatment of Relapsed Hematologic Malignancy After Allogeneic Stem Cell Transplant

BMT 2001-03
Phase II Trial of CD34 Selected Peripheral Blood Progenitor Cells with Immunoablation in the Treatment of Severe Autoimmune Disease

INCB 18424-258
An Open Label Assessment of Safety and Efficacy of Ruxolitinib (INCB018424) in Subjects With Primary Myelofibrosis, Post Essential Thrombocythemiamyelofibrosis and Post Polycythemia Vermayelofibrosis Who Have Platelet Counts of 50 x 109/L to 100 x 109/L
More Information

IV-ATG-SCT-01
A Randomized, Prospective, Double-Blind, Placebo-Controlled, Phase III Study of US-ATG-F Prophylaxis as a Supplement to Standard of Care Prophylaxis to Prevent Moderate to Severe Chronic GVHD in Adult Acute Myeloid Leukemia, Acute Lymphoid Leukemia, and Myelodysplastic Syndrome Patients After Allogeneic Stem Cell Transplantation from Unrelated Donors
More Information

10-005
A Randomized Controlled Study of Extracorporeal Photopheresis (ECP) Therapy with UVADEXTM for the Treatment of Patients with Moderate to Severe Chronic Graft-versus-Host Disease (cGvHD)
More Information


 

 

 

1430 Tulane Ave, New Orleans, LA 70112 504-988-5263 medsch@tulane.edu